Domestic pharmaceutical companies at international symposiums
Hanmi Pharm has attracted interests as announcing the clinical trial result of ‘Olita(generic name: olmutinib),’ a targeted therapy drug for lung cancer, at major academia conferences, such as 2014/2015 ASCO(American Society of Clinical Oncology), 2015 ESMO Asia(European Society for Medical Oncol...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
